ArticleThe Journal of infection2022

Pediatric patients with immune-mediated diseases on immunosuppressants have low risk of severe COVID-19 and no increase in flare rate after SARS CoV-2 exposure.

Alexis Virgil Cochino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.